| TRADE NAME |
ACTION |
COLLABORATION |
STAGE |
DONEPEX
(donepezil) |
cholinoesterase inhibitor |
In-house development /
distribution and pomotion by
GlaxoSmithKline Pharmaceuticals |
approved in Poland |
AROMEK
(letrozole) |
aromatase inhibitor |
In-house development |
approved in Poland |
KETREL
(quetiapinum) |
atypical antipsychotic |
In-house development |
approved in Poland |
VALZEK
(valsartanum) |
Angiotensin Receptor Blocker: ARBs |
In-house development |
approved in Poland |
| CELOPAQUE |
nonionic low- osmolar
contrast agent |
Interpharma
- Praha A.S., CZ |
Filed in Poland for
regulatory approval |
| LIGRASTIM |
Colony granulocyte
stimulating factor |
undisclosed |
Preparation for
regulatory filing |
| ENOPAX |
Low molecular heparin
in subcutaneous injection |
undisclosed |
Filed in Poland for
regulatory approval |
| STIMULAN |
Immunosuppressive
macrolide |
undisclosed |
Filed in Poland for
regulatory approval |
